BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37097904)

  • 21. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.
    Prall F; Dührkop T; Weirich V; Ostwald C; Lenz P; Nizze H; Barten M
    Hum Pathol; 2004 Jul; 35(7):808-16. PubMed ID: 15257543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
    Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
    Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology.
    Zeng L; Li SH; Xu SY; Chen K; Qin LJ; Liu XY; Wang F; Fu S; Deng L; Wang FH; Miao L; Li L; Liu N; Wang R; Wang HY
    Front Immunol; 2022; 13():878457. PubMed ID: 35619699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer.
    Wang F; Lu S; Cao D; Qian J; Li C; Zhang R; Wang F; Wu M; Liu Y; Pan Z; Wu X; Lu Z; Ding P; Li L; Lin J; Catteau A; Galon J; Chen G
    Oncoimmunology; 2023; 12(1):2161167. PubMed ID: 36632564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.
    Yu A; Mansure JJ; Solanki S; Siemens DR; Koti M; Dias ABT; Burnier MM; Brimo F; Kassouf W
    PLoS One; 2018; 13(10):e0205746. PubMed ID: 30308033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour budding/T cell infiltrates in colorectal cancer: proposal of a novel combined score.
    Dawson H; Christe L; Eichmann M; Reinhard S; Zlobec I; Blank A; Lugli A
    Histopathology; 2020 Mar; 76(4):572-580. PubMed ID: 31560788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker.
    Bell PD; Pai RK
    Histopathology; 2022 Dec; 81(6):696-714. PubMed ID: 35758208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.
    Furgiuele S; Descamps G; Lechien JR; Dequanter D; Journe F; Saussez S
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
    Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
    Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified and Optimized Immune Score for Colorectal Cancer Microenvironment.
    Nakane H; Sudo T; Kawahara A; Yomoda T; Shigaki T; Fujiyoshi K; Ohchi T; Koushi K; Yoshida T; Ogata T; Fujita F; Akagi Y
    Anticancer Res; 2023 Aug; 43(8):3793-3798. PubMed ID: 37500158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Idos GE; Kwok J; Bonthala N; Kysh L; Gruber SB; Qu C
    Sci Rep; 2020 Feb; 10(1):3360. PubMed ID: 32099066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoscore and its introduction in clinical practice.
    Galon J; Lanzi A
    Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):152-161. PubMed ID: 32107902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
    Kim Y; Bae JM; Li G; Cho NY; Kang GH
    PLoS One; 2015; 10(4):e0122183. PubMed ID: 25875774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.
    Ren J; Xu L; Zhou S; Ouyang J; You W; Sheng N; Yan L; Peng D; Xie L; Wang Z
    Front Oncol; 2021; 11():776997. PubMed ID: 34926285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TPL2 expression is correlated with distant metastasis and poor prognosis in colorectal cancer.
    Pyo JS; Park MJ; Kim CN
    Hum Pathol; 2018 Sep; 79():50-56. PubMed ID: 29763718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.
    Donnem T; Hald SM; Paulsen EE; Richardsen E; Al-Saad S; Kilvaer TK; Brustugun OT; Helland A; Lund-Iversen M; Poehl M; Olsen KE; Ditzel HJ; Hansen O; Al-Shibli K; Kiselev Y; Sandanger TM; Andersen S; Pezzella F; Bremnes RM; Busund LT
    Clin Cancer Res; 2015 Jun; 21(11):2635-43. PubMed ID: 25680376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The correlation of immunoscore and frailty in colorectal cancer.
    Nakao T; Shimada M; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Takasu C; Wada Y; Yoshimoto T; Yamashita S; Iwakawa Y
    Int J Clin Oncol; 2022 Mar; 27(3):528-537. PubMed ID: 34846645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of tumor-infiltrating lymphocytes in non-small cell lung carcinomas.
    Mlika M; Saidi A; Mejri N; Abdennadher M; Haddouchi C; Labidi S; Khiari H; Boussen H; Hsairi M; Mezni F
    Asian Cardiovasc Thorac Ann; 2022 Feb; 30(2):177-184. PubMed ID: 34558296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.